Quarterly report pursuant to Section 13 or 15(d)

Contingencies and commitments - Universal Cells Research, Collaboration and License Agreement and Co-development and Co-commercialization agreement (Details)

v3.23.2
Contingencies and commitments - Universal Cells Research, Collaboration and License Agreement and Co-development and Co-commercialization agreement (Details) - Collaboration and license agreement - Universal Cells, Inc.
 1 Months Ended 12 Months Ended
Feb. 29, 2016
USD ($)
Nov. 30, 2015
USD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Jun. 30, 2023
item
Dec. 31, 2022
USD ($)
Contingencies and commitments            
Upfront license and start-up fees   $ 2,500,000        
Milestone payments $ 3,000,000   $ 200,000 $ 900,000    
First milestone payment           $ 500,000
Second milestone payment           600,000
Third milestone payment           $ 400,000
Number of remaining milestones accrued | item         0